CompletedPhase 2NCT02612155

A Multi-site Study of Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy

Studying Neonatal hypoxic and ischemic brain injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Michael Cotten
Principal Investigator
Michael Cotten, MD
Duke University
Intervention
Infusion of autologous cord blood(biological)
Enrollment
35 enrolled
Eligibility
All sexes
Timeline
20172019

Study locations (1)

Collaborators

The Robertson Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02612155 on ClinicalTrials.gov

Other trials for Neonatal hypoxic and ischemic brain injury

Additional recruiting or active studies for the same condition.

See all trials for Neonatal hypoxic and ischemic brain injury

← Back to all trials